company-header-background
Newsroom
Read our latest press releases, learn about new products, for media inquiries contact Jane Alleva, Head of Marketing

LATEST NEWS

Press Release

CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials

Read More

PRESS RELEASES

IN THE NEWS

Stay Informed

Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.

MENU
菜单